Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …

Proton pump inhibitors (PPIs) reliably suppress gastric acid secretion and are therefore the
first‐line treatment for gastric acid‐related disorders. Hypomagnesemia (serum magnesium …

Abstract The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of
Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic …

The association between proton pump inhibitors (PPI) use and risk of acute interstitial
nephritis has been described. However, whether exposure to PPI associates with incident …

Objective Proton pump inhibitors (PPIs) are widely used, and their use is associated with
increased risk of adverse events. However, whether PPI use is associated with excess risk of …

Introduction: Magnesium is an essential element which also has pleiotropic effects in
humans. Recent studies have altered our interpretation of a disturbed magnesium balance …

Background: Previous meta-analyses have suggested that there might be an association
between the use of proton pump inhibitors (PPIs) and the development of hypomagnesemia …

Proton pump inhibitors (PPIs), long thought to be safe, are associated with a number of
nonkidney adverse health outcomes and several untoward kidney outcomes, including …

Although much is known about magnesium, its interactions with calcium and vitamin D are
less well studied. Magnesium intake is low in populations who consume modern processed …

Magnesium deficiency is prevalent in women of childbearing age in both developing and
developed countries. The need for magnesium increases during pregnancy, and the …